The content on this site is intended for healthcare professionals only
Prof Shai Izraeli speaks with ecancertv at BSH 2016 about the landscape of childhood leukaemia.
With the majority of childhood cases of ALL being curable, Prof Izraeli outlines avenues for further research: treating high-risk groups and reducing toxicity with targeted therapy.
He also addresses the clinical significance of genomic data for risk stratification and therapy identification.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Addressing the rise of multiple myeloma in Rwanda
Multiple myeloma in a resource constrained setting
Relapsed refractory multiple myeloma
Choosing Wisely in radiology Tanzania
Molecular profiling in prostate cancer: key challenges for clinical implementation
